These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7553956

  • 1. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Mao G, Gao Z, Wang Q.
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
    [Abstract] [Full Text] [Related]

  • 2. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
    Liu X.
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
    [Abstract] [Full Text] [Related]

  • 4. A new approach to the treatment of malignant effusion.
    Li DJ, Wang YR, Tan XY, Wang HZ, Yao XD, Ba DN.
    Chin Med J (Engl); 1990 Dec; 103(12):998-1002. PubMed ID: 2127253
    [Abstract] [Full Text] [Related]

  • 5. Treatment of 121 patients with malignant effusion due to advanced lung cancer by intrapleural transfer of autologous or allogeneic LAK cells combined with rIL-2.
    Liu X, Li D, Zhang C, Ba D, Liu J, Wan T, Li Z, Jin Y, He Y.
    Chin Med Sci J; 1993 Sep; 8(3):186-9. PubMed ID: 8142637
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
    Yasumoto K, Mivazaki K, Nagashima A, Ishida T, Kuda T, Yano T, Sugimachi K, Nomoto K.
    Cancer Res; 1987 Apr 15; 47(8):2184-7. PubMed ID: 3493843
    [Abstract] [Full Text] [Related]

  • 8. Treatment of patients with malignant pleural effusions due to advanced lung cancer by transfer of autologous LAK cells combined with rIL-2 or rIL-2 alone.
    Li D, Wang Y, Yao X, Shao J, Chen Y, Ba D.
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990 Apr 15; 5(1):51-5. PubMed ID: 2371266
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
    Suzuki H.
    Nihon Geka Gakkai Zasshi; 1989 Nov 15; 90(11):1922-31. PubMed ID: 2608022
    [Abstract] [Full Text] [Related]

  • 13. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases.
    Yanagawa H, Sone S, Fukuta K, Nishioka Y, Ogura T.
    Jpn J Clin Oncol; 1991 Oct 15; 21(5):377-83. PubMed ID: 1753419
    [Abstract] [Full Text] [Related]

  • 14. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2].
    Nakanishi M, Sone S, Ogura T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul 15; 29(7):824-8. PubMed ID: 1920977
    [Abstract] [Full Text] [Related]

  • 15. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
    Suzuki H, Abo S, Kitamura M, Hashimoto M, Izumi K.
    Surg Today; 1993 Jul 15; 23(12):1053-9. PubMed ID: 8118118
    [Abstract] [Full Text] [Related]

  • 16. [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients].
    Cao GW, Yang WG, Du P.
    Zhonghua Zhong Liu Za Zhi; 1994 Nov 15; 16(6):428-31. PubMed ID: 7720497
    [Abstract] [Full Text] [Related]

  • 17. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
    Sone S, Yanagawa H, Nii A, Ozaki T, Ogura T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug 15; 30(8):1434-40. PubMed ID: 1434216
    [Abstract] [Full Text] [Related]

  • 18. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H, Yamaguchi Y.
    Cancer; 1997 Jul 01; 80(1):42-9. PubMed ID: 9210707
    [Abstract] [Full Text] [Related]

  • 19. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N.
    Gan To Kagaku Ryoho; 1999 Oct 01; 26(12):1796-800. PubMed ID: 10560397
    [Abstract] [Full Text] [Related]

  • 20. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Oct 01; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.